GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Ghrelin ameliorates acute lung injury induced by oleic acid via inhibition of endoplasmic reticulum stress.
Tian. Xiuli X; Liu. Zhijun Z; Yu. Ting T; Yang. Haitao H; Feng. Linlin L
Key Findings
- Rats with acute lung injury had lower blood and lung levels of ghrelin.
- Administering ghrelin (10 nmol/kg) reduced lung inflammation, fluid buildup, and improved oxygen/CO₂ levels.
- Ghrelin antagonists increased injury severity, and the protective effect of ghrelin was blocked when endoplasmic reticulum stress was artificially induced.
Practical Outcomes
- The study shows ghrelin can protect lung tissue in a specific injury model, but it is an early animal experiment with no human dosing guidance. For biohackers, there is no immediate protocol to apply, though it hints at future therapeutic possibilities for lung health.
Summary
In a rat study, giving the hormone ghrelin helped protect the lungs from severe damage caused by oleic acid, likely by lowering stress inside the cells' endoplasmic reticulum. Blocking ghrelin made the injury worse.
Abstract
Acute lung injury (ALI) is associated with excessive mortality and lacks appropriate therapy. Ghrelin is a novel peptide that protects the lung against ALI. This study aimed to investigate whether endoplasmic reticulum stress (ERS) mediates the protective effect of ghrelin on ALI. We used a rat oleic acid (OA)-induced ALI model. Pulmonary impairment was detected by hematoxylin and eosin (HE) staining, lung mechanics, wet/dry weight ratio, and arterial blood gas analysis. Plasma and lung content of ghrelin was examined by ELISA, and mRNA expression was measured by quantitative real-time PCR. Protein levels were detected by western blot. Rats with OA treatment showed significant pulmonary injury, edema, inflammatory cellular infiltration, cytokine release, hypoxia and CO<sub>2</sub> retention as compared with controls. Plasma and pulmonary content of ghrelin was reduced in rats with ALI, and mRNA expression was downregulated. Ghrelin (10nmol/kg) treatment ameliorated the above symptoms, but treatment with the ghrelin antagonists D-Lys<sup>3</sup> GHRP-6 (1μmol/kg) and JMV 2959 (6mg/kg) exacerbated the symptoms. ERS induced by OA was prevented by ghrelin and augmented by ghrelin antagonist treatment. The ERS inducer, tunicamycin (Tm) prevented the ameliorative effect of ghrelin on ALI. The decreased ratio of p-Akt and Akt induced by OA was improved by ghrelin treatment, and was further exacerbated by ghrelin antagonists. Ghrelin protects against ALI by inhibiting ERS. These results provide a new target for prevention and therapy of ALI.
Study Information
pubmed
2017
2017-07-24T00:00:00.000Z
10.1016/j.lfs.2017.07.023
11
40